Latest Licensing News

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

Opyl Limited reports strong progress in AI-driven clinical trial optimisation with active commercial initiatives, strategic partnerships, and a planned capital raise to support growth amid tight cash reserves.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Resource Mining Corporation (ASX: RMI) reported promising initial gold assays from its Saudi Arabian projects and is evaluating near-term gold production in Tanzania, while managing a constrained cash position and new funding arrangements.

American Rare Earths has expanded its Halleck Creek rare earth resource by 12.2% and achieved a metallurgical breakthrough that slashes processing volumes by over 90%, underpinning a robust updated scoping study with strong financial metrics.

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Elementos Limited has delivered a robust Definitive Feasibility Study for its Oropesa Tin Project in Spain, secured key partnerships, and commenced new drilling at its Cleveland Project in Tasmania, all against a backdrop of rising tin prices driven by global supply disruptions.

Terra Uranium Limited has expanded its exploration portfolio by acquiring LCT Metals, adding tin and precious metals projects in New South Wales, while advancing uranium exploration in Canada’s Athabasca Basin through strategic partnerships and drill-ready targets.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

eMetals Limited has completed initial field activities at its Busia Gold Project in Uganda, with soil and rock chip sampling underway and results pending. The company also reports ongoing exploration potential at its Mubende Gold Project and maintains a robust cash balance of nearly $3 million.

Global Uranium and Enrichment Limited has significantly expanded its Pine Ridge Uranium Project landholding in Wyoming’s Powder River Basin by approximately 85%, adding 937 new claims and enhancing exploration potential in a premier U.S. uranium district.

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.